Login Register Cart 0
Generic placeholder image

Applied Clinical Research, Clinical Trials and Regulatory Affairs

Editor-in-Chief

ISSN (Print): 2213-476X
ISSN (Online): 2213-4778

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Implementing Haemovigilance in India as a National Perspective

Author(s): Vignesh Mano and Raman S. Kumar*

Volume 7, Issue 1, 2020

Page: [30 - 36] Pages: 7

DOI: 10.2174/2213476X06666190715162937

Abstract

Haemovigilance is an organized and effective process of monitoring, identifying, reporting, investigating and analyzing adverse events and reactions in case of blood transfusion and during the manufacturing process of blood products. This system ensures the quality and safety aspects of blood transfusion, that bring out corrective and preventing actions and advancement in the transfusion system. Nowadays, most of the developed countries have implemented Haemovigilance in order to monitor adverse reactions and events associated with blood donation and transfusion. This review article is about steps that are required to be taken for the implementation of Haemovigilance on a National level as an Indian perspective.

Keywords: Haemovigilance, adverse reactions, regulatory requirements, benefits, blood transfusion, acute haemolytic.

« Previous Next »
Graphical Abstract

[1]
Marwaha N, Singh S, Bisht A. Setting up haemovigilance from the very first step. The Indian perspective, 2014 International society of blood transfusion. ISBT Sci Ser 2014; 9(1): 178-83.
[http://dx.doi.org/10.1111/voxs.12084]
[2]
Haemovigilance programme of India. . National institute of biologicals and indian pharmacopoeia commission collaboration 2013.Available from: http://www.nib.gov.in/haemovigilance.html
[3]
Blood transfusion error attorneys. Available from: https://www.boyerslaw.com/blood-transfusion-errors-malpractice.html
[4]
Mukherjee S, Maiti R. Haemovigilance: A Current update in Indian perspective. J Clin Diagn Res 2016; 10(11): EE05-9.
[http://dx.doi.org/10.7860/JCDR/2016/21029.8868] [PMID: 28050389]
[5]
Sanvidhan GS, Kosta P, Harsh N. Role of pharmacovigilance in India: an overview. Online J Public Health Inform 2015; 7(2)e223
[6]
de Vries RRP, Faber J-C, Strengers PFW. Haemovigilance: an effective tool for improving transfusion practice. Vox Sang 2011; 100(1): 60-7.
[http://dx.doi.org/10.1111/j.1423-0410.2010.01442.x] [PMID: 21175656]
[7]
Sreekumar PK, Partha SG, Gupta D. Paramod KTM. Haemovigilance in India - A milestone in transfusion safety. Int J Health Sci Res 2017; 7(2): 18819-24.
[8]
Ramani KV, Mavalankar DV, Govil D. Study of blood-transfusion services in Maharashtra and Gujarat States, India. J Health Popul Nutr 2009; 27(2): 259-70.
[http://dx.doi.org/10.3329/jhpn.v27i2.3368] [PMID: 19489420]
[9]
Sreekumar PK, Pramod KTM, Partha SG. Debasish Gupta, Pallavi. Haemovigilance and its significance in transfusion safety. Int J Drug Res Tech 2016; 6(4): 245-9.
[10]
Neelam M. Haemovigilance programme of India, current scenario and future perspectives Available from: http://transmedcon2015.com
[11]
Akanksha B, Surinder S, and Neelam M. National blood donor vigilance program. Asian J Transfus Sci 2016; 10(1): 1-2.
[http://dx.doi.org/10.4103/0973-6247.175384]
[12]
Bisht A, Singh S, Marwaha N. National blood donor vigilance programme: India. Asian J Transfus Sci 2016; 10(1): 1-2.
[http://dx.doi.org/10.4103/0973-6247.175384] [PMID: 27011662]
[13]
IPC-NIB guidance document for reporting serious adverse reactions in blood transfusion service National Institute of Biologicals & Indian Pharmacopoeia Commission Collaboration. 2015.[Accessed: 21 September 2015] Available from: http://nib.gov.in/hae movigilance.html

Rights & Permissions Print Cite
Article Metrics
4
© 2024 Bentham Science Publishers | Privacy Policy